BRAF and melanoma: While many tertiary care centers and specialized melanoma programs have or are actively implementing reflex BRAF mutation testing, it is paramount to promote this change across community hospitals as well, so that patients with high-risk (stage ≥IIB) melanoma can consistently arrive to their first medical oncology appointment with this information at hand to make an informed treatment decision.